Explore more publications!
STEM Review Turks & Caicos
Got News to Share?

STEM Review Turks & Caicos: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Review Turks & Caicos.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 24, 2025

Gostex Launches AI-Powered White-Label Payments Suite
October 24, 2025

Gostex Launches AI-Powered White-Label Payments Suite

Indeterminate GlobeNewswire
Ethereum-Based Mutuum Finance (MUTM) Nears Next Price Step With 60% of Phase 6 Already Sold
October 24, 2025

Ethereum-Based Mutuum Finance (MUTM) Nears Next Price Step With 60% of Phase 6 Already Sold

Indeterminate GlobeNewswire
Berry Launches AI-Driven Crypto Platform to Help Users Track BTC and XRP Market Trends
October 24, 2025

Berry Launches AI-Driven Crypto Platform to Help Users Track BTC and XRP Market Trends

Indeterminate GlobeNewswire
Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference
October 24, 2025

Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference

Indeterminate GlobeNewswire
Snail Games Highlights Portfolio Momentum Following Rebel Engine’s Strong Steam Next Fest Performance
October 24, 2025

Snail Games Highlights Portfolio Momentum Following Rebel Engine’s Strong Steam Next Fest Performance

Indeterminate GlobeNewswire
SEALSQ Announces Uplisting to NASDAQ Global Select Market; Reaches $1 Billion Market Capitalization
October 24, 2025

SEALSQ Announces Uplisting to NASDAQ Global Select Market; Reaches $1 Billion Market Capitalization

Indeterminate GlobeNewswire
Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051
October 24, 2025

Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051

Indeterminate GlobeNewswire
AlphaTON Capital Appoints Wes Levitt as Chief Financial Officer
October 24, 2025

AlphaTON Capital Appoints Wes Levitt as Chief Financial Officer

Indeterminate GlobeNewswire
Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025
October 24, 2025

Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025

Indeterminate GlobeNewswire
Arcutis to Present New Quality of Life and Long-Term Data with ZORYVE® (roflumilast) Cream 0.15% and 0.05% for the Treatment of Atopic Dermatitis at the Fall Clinical Dermatology Conference
October 24, 2025

Arcutis to Present New Quality of Life and Long-Term Data with ZORYVE® (roflumilast) Cream 0.15% and 0.05% for the Treatment of Atopic Dermatitis at the Fall Clinical Dermatology Conference

Indeterminate GlobeNewswire
23andMe Research Institute Names Brad Margus and Stephen Quake, D.Phil., to Board of Directors
October 24, 2025

23andMe Research Institute Names Brad Margus and Stephen Quake, D.Phil., to Board of Directors

Indeterminate GlobeNewswire
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
October 24, 2025

NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population

Indeterminate GlobeNewswire
Biogen Licenses Oral C5aR1 Antagonist from Vanqua Bio to Expand Immunology Portfolio
October 24, 2025

Biogen Licenses Oral C5aR1 Antagonist from Vanqua Bio to Expand Immunology Portfolio

Indeterminate GlobeNewswire
Kura Oncology Receives $30 Million Development Milestone Payment in Ziftomenib AML Program with Kyowa Kirin
October 24, 2025

Kura Oncology Receives $30 Million Development Milestone Payment in Ziftomenib AML Program with Kyowa Kirin

Indeterminate GlobeNewswire
BitMart Launches Halloween “Trick or Trade” Event as BMX Gains Market Momentum and BitMart Card Adoption Accelerates
October 24, 2025

BitMart Launches Halloween “Trick or Trade” Event as BMX Gains Market Momentum and BitMart Card Adoption Accelerates

Indeterminate GlobeNewswire
Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2025 on the Potential of MRT-6160, a VAV1-directed Molecular Glue Degrader, to Treat Immune-mediated Diseases
October 24, 2025

Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2025 on the Potential of MRT-6160, a VAV1-directed Molecular Glue Degrader, to Treat Immune-mediated Diseases

Indeterminate GlobeNewswire
Aeluma Quantum Photonics Paper Accepted to SPIE Photonics West Conference January 17 – 22, 2026 in San Francisco, California
October 24, 2025

Aeluma Quantum Photonics Paper Accepted to SPIE Photonics West Conference January 17 – 22, 2026 in San Francisco, California

Indeterminate GlobeNewswire
New Crypto Mutuum Finance (MUTM) Crosses $17.8 Million Raised as Holder Count Nears 17,500
October 24, 2025

New Crypto Mutuum Finance (MUTM) Crosses $17.8 Million Raised as Holder Count Nears 17,500

Indeterminate GlobeNewswire
Profound Named to Redpoint Ventures’ Inaugural AI64 List of the Most Promising AI Companies
October 24, 2025

Profound Named to Redpoint Ventures’ Inaugural AI64 List of the Most Promising AI Companies

Indeterminate GlobeNewswire
GigaCloud Technology Inc Announces Planned Acquisition of New Classic Home Furnishings
October 24, 2025

GigaCloud Technology Inc Announces Planned Acquisition of New Classic Home Furnishings

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions